Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $5.84 $8.40 Friday, 10th May 2024 VERV stock ended at $6.01. This is 5.50% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 9.35% from a day low at $5.88 to a day high of $6.43.
90 days $5.84 $19.34
52 weeks $5.84 $21.42

Historical Verve Therapeutics, Inc. prices

Date Open High Low Close Volume
Mar 02, 2023 $18.25 $20.86 $17.58 $20.16 1 421 068
Mar 01, 2023 $18.91 $19.12 $18.02 $18.19 471 739
Feb 28, 2023 $18.83 $19.34 $18.73 $19.00 503 803
Feb 27, 2023 $18.94 $19.21 $18.66 $18.93 599 003
Feb 24, 2023 $19.02 $19.50 $18.40 $18.62 699 889
Feb 23, 2023 $20.01 $20.05 $18.65 $19.54 711 868
Feb 22, 2023 $19.14 $20.15 $19.01 $20.00 1 069 422
Feb 21, 2023 $20.34 $20.62 $18.97 $18.99 772 811
Feb 17, 2023 $20.62 $21.13 $19.51 $21.10 618 698
Feb 16, 2023 $21.17 $21.49 $20.42 $20.59 635 682
Feb 15, 2023 $21.45 $21.74 $20.81 $21.72 489 281
Feb 14, 2023 $20.98 $22.12 $20.52 $21.76 498 916
Feb 13, 2023 $20.36 $21.30 $19.93 $21.14 378 557
Feb 10, 2023 $20.53 $20.67 $19.77 $20.45 642 127
Feb 09, 2023 $21.54 $22.03 $20.25 $20.40 572 174
Feb 08, 2023 $22.52 $23.54 $21.04 $21.12 541 628
Feb 07, 2023 $22.67 $22.99 $21.71 $22.68 631 127
Feb 06, 2023 $22.99 $22.99 $22.14 $22.57 432 474
Feb 03, 2023 $23.23 $24.29 $22.92 $23.29 561 349
Feb 02, 2023 $22.69 $24.69 $22.15 $24.01 1 010 713
Feb 01, 2023 $22.56 $22.63 $20.70 $22.07 778 476
Jan 31, 2023 $21.90 $23.13 $21.85 $22.75 448 591
Jan 30, 2023 $22.10 $22.43 $21.50 $21.77 420 295
Jan 27, 2023 $21.78 $22.92 $21.78 $22.42 574 188
Jan 26, 2023 $22.38 $22.67 $21.49 $22.01 393 019
Click to get the best stock tips daily for free!

About Verve Therapeutics, Inc.

Verve Therapeutics. Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with... VERV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT